Tamoxifen as Systemic Treatment of Advanced Breast Cancer during Pregnancy—Case Report and Literature Review
- 31 March 2001
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 80 (3) , 405-408
- https://doi.org/10.1006/gyno.2000.6080
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Chemotherapy for Metastatic Melanoma during PregnancyGynecologic Oncology, 1997
- The effects of the antihormones RU486 and tamoxifen on fetoplacental development and placental bed vascularisation in the rat: a model for intrauterine fetal growth retardationBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Teratogen update: Carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in uteroTeratology, 1995
- Goldenhar's Syndrome Associated With Tamoxifen Given to the Mother During GestationPublished by American Medical Association (AMA) ,1994
- Breast cancer during pregnancyCancer, 1994
- The role of tamoxifen in the treatment and prevention of breast cancerCurrent Problems in Cancer, 1992
- Maternal Malignancy Metastatic to the Products of ConceptionObstetrical & Gynecological Survey, 1989
- The effects of Nolvadex (tamoxifen citrate; ICI 46,474) on pregnancy in rabbitsReproduction, 1976